Key points are not available for this paper at this time.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most common chronic liver disease worldwide. It is important to develop noninvasive tests to assess the disease severity and prognosis.
Lin et al. (Thu,) studied this question.